Skip to content
10-Q

Quarterly Report

LifeMD, Inc. LFMD LFMDP

0001493152-25-023906

← back to feed
Filed
Nov 17, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 48.14M sh
Shares Diluted Q3 2025 · Sep 30, 2025 46.16M sh
Shares Diluted Q3 2025 · Sep 30, 2025 44.58M sh
Shares Diluted Q3 2025 · Sep 30, 2024 42.02M sh
Shares Diluted Q3 2025 · Sep 30, 2024 40.86M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $270K
Capex Q3 2025 · Sep 30, 2025 $1.72M
Capex Q3 2025 · Sep 30, 2024 $1.27M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $11.56M
Operating Cash Flow Q3 2025 · Jun 30, 2025 $11.71M
Operating Cash Flow Q3 2025 · Mar 31, 2025 $3.07M
Operating Cash Flow Q3 2025 · Dec 31, 2024 $17.51M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 $16.44M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.31M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$9.08M
Current Liabilities Q3 2025 · Sep 30, 2025 $56.66M
Current Liabilities Q3 2025 · Dec 31, 2024 $67.4M
Total Liabilities Q3 2025 · Sep 30, 2025 $62.62M
Total Liabilities Q3 2025 · Dec 31, 2024 $83.65M
Current Assets Q3 2025 · Sep 30, 2025 $41.09M
Current Assets Q3 2025 · Dec 31, 2024 $52.37M
Total Assets Q3 2025 · Sep 30, 2025 $65.98M
Total Assets Q3 2025 · Dec 31, 2024 $76.1M
Sga Expense Q3 2025 · Sep 30, 2025 $16.59M
Sga Expense Q3 2025 · Sep 30, 2025 $51.21M
Sga Expense Q3 2025 · Dec 31, 2024 $71.18M
Sga Expense restated Q3 2025 · Sep 30, 2024 $18.12M
Sga Expense restated Q3 2025 · Sep 30, 2024 $51.16M
Net Income Q3 2025 · Sep 30, 2025 −$3.81M
Net Income Q3 2025 · Sep 30, 2025 −$5.61M
Net Income Q3 2025 · Jun 30, 2025 −$1.62M
Net Income Q3 2025 · Jun 30, 2025 −$1.8M
Net Income Q3 2025 · Mar 31, 2025 −$183.78K
Net Income Q3 2025 · Dec 31, 2024 −$21.41M
Net Income restated Q3 2025 · Sep 30, 2024 −$4.66M
Net Income restated Q3 2025 · Sep 30, 2024 −$16.47M
Operating Income Q3 2025 · Sep 30, 2025 −$1.97M
Operating Income Q3 2025 · Sep 30, 2025 −$1.45M
Operating Income Q3 2025 · Jun 30, 2025 −$451.56K
Operating Income Q3 2025 · Jun 30, 2025 $522.78K
Operating Income Q3 2025 · Mar 31, 2025 $974.34K
Operating Income Q3 2025 · Dec 31, 2024 −$18.28M
Operating Income restated Q3 2025 · Sep 30, 2024 −$4M
Operating Income restated Q3 2025 · Sep 30, 2024 −$14.43M
Gross Profit Q3 2025 · Sep 30, 2025 $52.76M
Gross Profit Q3 2025 · Sep 30, 2025 $163.49M
Gross Profit Q3 2025 · Jun 30, 2025 $55.24M
Gross Profit Q3 2025 · Jun 30, 2025 $110.73M
Gross Profit Q3 2025 · Mar 31, 2025 $55.49M
Gross Profit Q3 2025 · Dec 31, 2024 $184.77M
Gross Profit restated Q3 2025 · Sep 30, 2024 $48.26M
Gross Profit restated Q3 2025 · Sep 30, 2024 $134.7M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $7.41M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $23.48M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $5.01M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $14.64M
Revenue Q3 2025 · Sep 30, 2025 $60.17M
Revenue Q3 2025 · Sep 30, 2025 $186.98M
Revenue Q3 2025 · Jun 30, 2025 $62.67M
Revenue Q3 2025 · Jun 30, 2025 $126.8M
Revenue Q3 2025 · Mar 31, 2025 $64.13M
Revenue Q3 2025 · Dec 31, 2024 $208.84M
Revenue restated Q3 2025 · Sep 30, 2024 $53.27M
Revenue restated Q3 2025 · Sep 30, 2024 $149.34M
Eps Diluted Q3 2025 · Jun 30, 2025 −$0.05
Eps Diluted Q3 2025 · Jun 30, 2025 −$0.08
Eps Diluted Q3 2025 · Mar 31, 2025 −$0.02
Eps Diluted Q3 2025 · Dec 31, 2024 −$0.60
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.46
Eps Basic Q3 2025 · Jun 30, 2025 −$0.05
Eps Basic Q3 2025 · Jun 30, 2025 −$0.08
Eps Basic Q3 2025 · Mar 31, 2025 −$0.02
Eps Basic Q3 2025 · Dec 31, 2024 −$0.60
Eps Basic Q3 2025 · Sep 30, 2024 −$0.13
Eps Basic Q3 2025 · Sep 30, 2024 −$0.46
Stock Issued Q3 2025 · May 29, 2025 388.65K sh
Stock Issued Q3 2025 · Nov 15, 2023 79.33K sh